The Need for Speed: Creating Value in a Devalued Biotech Market Webinar

Recently, Biopharma and Life Science companies are facing dramatic devaluations which have made a negative impact on private funding and have left growing companies navigating a series of complex decisions as their business grows. 

 

Listen in as SmartLabs Co-Founder/CBO, Seth Taylor, moderates a discussion with Todd Foley, Managing Director of MPM Capital, and Chad Cowen, CEO of Clade Therapeutics, on the current market and its implications for growing companies.